Lonza Group AG
LZAGY | OTC
$79.20
+$1.24 (+1.59%)
Nov 2, 2026, 11:43 AM ET · Market open
+1.59%
(1D)No price chart data available for 1D timeframe.
Rating
38.5
+15.3 ptsFundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #567/1028 (Top 55%)
Key Statistics
Market Data
Market Cap $56.35B
1D Range
78.82 79.28
52W Range
58.78 79.28
Valuation (TTM)
PE -39.83
PB 5.51
EV/EBITDA 22.50
Valuation (NTM)
Forward PE 30.09
Forward PEG -39.46
Price Target $0.00
Cash Flow
FCF Yield 0.4%
SBC Adj. FCF Yield 0.4%
SBC Impact N/A
Margins
Gross Margin 36.5%
Operating Margin 24.6%
FCF Margin 2.6%
Growth (CAGR)
Revenue 3Y | 5Y 6.9% |
10.1%
Dil EPS 3Y | 5Y -134.9% |
-20.4%
FCF 3Y | 5Y -25.8% |
-19.9%
Returns
ROA -0.6%
ROE -1.3%
ROIC 8.6%
Financial Health
Net Debt
CHF3.68B ($4.55B)
Current Ratio 1.66
Interest Coverage 13.18
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Biologics, Small Molecules, Cell and Gene, Capsule and Health...
Sector Healthcare
Industry Biotechnology
Employees 16,866
IPO Date Jan 20, 2010
Website www.lonza.com
Fiscal Year n/a
Latest News
19 days ago · seekingalpha.com
Lonza Group AG (LZAGY) Analyst/Investor Day TranscriptLonza Group AG (LZAGY) Analyst/Investor Day Transcript
2 months ago · seekingalpha.com
Lonza Group AG (LZAGY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptLonza Group AG (LZAGY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Add to Watchlist
Select watchlists to add or remove LZAGY